Synlogic Inc Cash Flow Conversion Efficiency
Synlogic Inc cash flow conversion efficiency. Based on the latest financial reports, Synlogic Inc (SYBX) has a cash flow conversion efficiency ratio of -0.078x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-923.00K) by net assets ($11.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Synlogic Inc (2013–2025)
Cash flow conversion efficiency of Synlogic Inc from 2013 to 2025. This chart illustrates how Synlogic Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Synlogic Inc stock price for real-time trading data and today's change.
Synlogic Inc Cash Flow Conversion Ratio Explained
Synlogic Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Synlogic Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Synlogic Inc ranked by their cash flow conversion efficiency. Also see Synlogic Inc (SYBX) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yimutian Inc. American Depositary Shares
NASDAQ:YMT
|
0.001x |
|
Tigi Ltd
TA:TIGI
|
-1.090x |
|
Vineet Laboratories Limited
NSE:VINEETLAB
|
0.088x |
|
Conduit Holdings Ltd
LSE:CRE
|
0.160x |
|
Lombard et Medot SA
PA:MLCAC
|
N/A |
|
Mcnally Bharat Engineering Company Limited
NSE:MBECL
|
0.000x |
|
Lincoln Mining Corp
V:LMG
|
0.119x |
|
Saray Matbaacilik Kagitcilik Kirtasiyecilik Ticaret ve Sanayi AS
IS:SAMAT
|
-0.082x |
Annual Cash Flow Conversion Efficiency for Synlogic Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Synlogic Inc from 2013 to 2025. Review SYBX financial flexibility score to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $11.86 Million | $-4.36 Million | -0.367x | +85.20% |
| 2024-12-31 | $12.75 Million | $-31.66 Million | -2.483x | -105.18% |
| 2023-12-31 | $42.66 Million | $-51.61 Million | -1.210x | -75.72% |
| 2022-12-31 | $82.61 Million | $-56.89 Million | -0.689x | -94.28% |
| 2021-12-31 | $147.27 Million | $-52.20 Million | -0.354x | -3.18% |
| 2020-12-31 | $115.14 Million | $-39.55 Million | -0.344x | +28.58% |
| 2019-12-31 | $156.91 Million | $-75.47 Million | -0.481x | -40.54% |
| 2018-12-31 | $124.10 Million | $-42.47 Million | -0.342x | +6.29% |
| 2017-12-31 | $85.04 Million | $-31.05 Million | -0.365x | +11.15% |
| 2016-12-31 | $60.35 Million | $-24.80 Million | -0.411x | -65.33% |
| 2015-12-31 | $85.02 Million | $-21.14 Million | -0.249x | -185.33% |
| 2014-12-31 | $-47.95 Million | $-13.97 Million | 0.291x | +34.16% |
| 2013-12-31 | $-29.91 Million | $-6.50 Million | 0.217x | -- |
About Synlogic Inc
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.